Retraction
Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
Paper Information
Record ID:
57342
Author(s):
Journal:
Publication Date:
November 28, 2021
Retraction Date:
January 09, 2024
(1.9 year years ago)
Subjects:
Institutions:
- Ege University, Faculty of Medicine, Department of Medical Genetics, 35100, Bornova, Izmir, Turkey
- Aydin Adnan Menderes University, Faculty of Medicine, Department of Medical Biology, 09100 Aydin, Turkey
- Ege University, Faculty of Medicine, Department of Pediatrics, 35100, Bornova, Izmir, Turkey
- Ege University, Faculty of Medicine, Department of Medical Biology, 35100, Bornova, Izmir, Turkey
- Ege University, Institute of Health Sciences, 35100, Bornova, Izmir, Turkey
Country:
🇹🇷 TurkeyArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations1
Post-Retraction(9.1%)
9
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
458
Days since retraction (latest)
Elucidating the genetic mechanism of anti-cancer efficacy of prednisolone in acute lymphoblastic leukemia through anti-miRNA treatments
Neslihan Pınar Özateş, Bakiye Göker Bağca, Duygu Arican et al. (5 authors)
Gene Reports
Published: Apr 2025
458 days after retraction
Retracted: Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2024
Same day as retraction
miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia
Eleni Tsotridou, Elisavet Georgiou, Athanasios Tragiannidis et al. (9 authors)
Oncology Letters
Open Access
Published: Dec 2023
1 citation
1 citation
19 days before retraction
Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment
M. A. Shervashidze, D. S. Smirnova, Т. Т. Валиев et al. (5 authors)
Педиатрическая фармакология
Open Access
Published: Aug 2023
140 days before retraction
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
Mahdiyar Iravani Saadi, Mohsen Nikandish, Zahra Ghahramani et al. (12 authors)
Journal of the Egyptian National Cancer Institute
Open Access
Published: Jun 2023
4 citations
4 citations
204 days before retraction
The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
Karolina Ziętara, Jan Lejman, Katarzyna Wojciechowska et al. (4 authors)
Cancers
Open Access
Published: Jan 2023
6 citations
6 citations
365 days before retraction
A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
Paulina Drożak, Łukasz Bryliński, Joanna Zawitkowska
Cancers
Open Access
Published: Nov 2022
9 citations
9 citations
434 days before retraction
MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools
Ioannis Kyriakidis, Konstantinos Kyriakidis, Aspasia Tsezou
Cancers
Open Access
Published: Aug 2022
19 citations
19 citations
510 days before retraction
Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers
Olga Sukocheva, Junqi Liu, Маргарита Е. Неганова et al. (9 authors)
Seminars in Cancer Biology
Published: May 2022
35 citations
35 citations
595 days before retraction
Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
Zsuzsanna Gaál
International Journal of Molecular Sciences
Open Access
Published: May 2022
11 citations
11 citations
596 days before retraction
In-Silico modulation of Interleukin-8 (IL8) for the therapeutic management of endodontic pulpitis
Nezar Boreak, Shilpa Bhandi
Saudi Journal of Biological Sciences
Open Access
Published: Oct 2021
8 citations
8 citations
806 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025